Elder Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Jun ' 14	Jun ' 13	Mar ' 12	Mar ' 11	Mar ' 10

Sources of funds

Owner's fund

Equity share capital

20.57

20.57

20.57

20.57

18.89

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

765.03

757.26

671.19

590.55

455.78

Loan funds

Secured loans

224.71

632.27

503.17

571.54

404.09

Unsecured loans

319.93

339.99

277.70

163.81

138.88

Total

1,330.23

1,750.09

1,472.63

1,346.46

1,017.63

Uses of funds

Fixed assets

Gross block

599.80

640.71

627.81

570.94

535.40

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

164.89

156.48

120.20

95.17

70.10

Net block

434.91

484.23

507.61

475.77

465.31

Capital work-in-progress

304.26

268.36

191.01

93.03

65.74

Investments

3.73

3.90

21.09

10.87

19.68

Net current assets

Current assets, loans & advances

1,192.87

1,451.74

994.63

951.56

614.32

Less : current liabilities & provisions

605.54

458.14

241.71

184.77

147.41

Total net current assets

587.33

993.60

752.91

766.79

466.91

Miscellaneous expenses not written

-

-

-

-

-

Total

1,330.23

1,750.09

1,472.63

1,346.46

1,017.63

Notes:

Book value of unquoted investments

3.19

3.35

20.17

9.95

18.75

Market value of quoted investments

3.77

2.41

4.80

4.13

4.21

Contingent liabilities

166.95

217.81

300.86

108.55

20.60

Number of equity sharesoutstanding (Lacs)

205.37

205.37

205.37

205.37

188.57